Carbohydrate-derived bicyclic selenazolines as new dual inhibitors (cholinesterases/OGA) against Alzheimer's disease

Velueta-Viveros, M., Martinez-Bailen, M., Puerta, A., Romero-Hernandez, L. L., Křen, V., Merino-Montiel, P., Montiel-Smith, S., Fernandes, M. X., Moreno-Vargas, A. J., Padron, J. M., Lopez, O., Fernandez-Bolanos, J. G. Carbohydrate-derived bicyclic selenazolines as new dual inhibitors (cholinesterases/OGA) against Alzheimer's disease. Bioorganic Chemistry. 2022, 127(OCT 2022), 105983. ISSN 0045-2068. E-ISSN 1090-2120. Available: doi: 10.1016/j.bioorg.2022.105983.